Identification of Anti-Inflammatory Active Constituents in Xuanfei Baidu Granule

Haoran Li,Lingyun Zhao,Zhou Liang,Zhiyan Wang,C. Hu,Yi Wang,Shufang Wang
DOI: https://doi.org/10.2139/ssrn.4617372
2023-01-01
Abstract:The Xuanfei Baidu (XFBD) prescription has demonstrated significant anti-inflammatory activity. However, the number of its reported constituents is limited, and its anti-inflammatory constituents are unclear. In this study, the constituents of XFBD granule, a granule dosage of XFBD prescription, were thoroughly examined in vitro and in vivo using liquid chromatography-quadruple time-of-flight mass spectrometry, and the anti-inflammatory constituents were screened. A total of 214 constituents were identified in the XFBD granule, 62 of which were confirmed via comparison with reference standards. After intragastric administration of XFBD granule, 63 constituents were absorbed into the serums of rats in the form of a prototype, and 28 constituents were distributed to the lungs of rats. XFBD granule and XFBD-containing serum could significantly reduce the NO and IL-6 secretion in LPS-induced RAW264.7 cell. Five anti-inflammatory constituents (verbasoside, scutellarin, luteolin, apigenin, and pogostone) were found to dose-dependently reduce the concentration of NO and IL-6. This study provided a valuable reference for the discovery of effective constituents of XFBD granule.
What problem does this paper attempt to address?